Day: December 21, 2021

Timbercreek Financial Declares December 2021 Dividend

Timbercreek Financial Declares December 2021 Dividend

TORONTO, Dec. 21, 2021 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) is pleased to announce that it has declared a monthly cash dividend of $0.0575 per common share (“Common Share”) of the Company to be paid on January 14, 2022 to holders of Common Shares of record on December 31, 2021. The Company also offers a Dividend Reinvestment Plan (the “Plan”), which is eligible to holders of Common Shares and provides a convenient means to purchase additional Common Shares by reinvesting cash dividends at a potential discount and without having to pay commissions, service charges or brokerage fees. Pursuant to the Plan and at the discretion of Timbercreek Capital Inc., the Manager, Common Shares will be acquired in the open market at prevailing prices or issued from treasury at 98 percent of the average market price...

Continue reading

PATAGONIA GOLD ANNOUNCES UPDATE ON MINING DEVELOPMENTS IN PROVINCE OF CHUBUT, ARGENTINA

PATAGONIA GOLD ANNOUNCES UPDATE ON MINING DEVELOPMENTS IN PROVINCE OF CHUBUT, ARGENTINA

Vancouver, BC., Dec. 21, 2021 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces the recent amendments to the provincial mining law in the Province of Chubut, Argentina regarding mining zoning (see the Company’s press release on December 17, 2021) have been repealed. On December 20, 2021, the Chubut Governor, Mariano Arcioni, sent a bill to the legislature of the Province of Chubut to retract the recent amendments as a result of the violent demonstrations that occurred soon after such law was enacted. This bill, which revoked the amendments regarding mining zoning, was passed by the legislature of the Province of Chubut on December 21, 2021. About Patagonia Gold Patagonia Gold Corp. is a South America focused, publicly traded mining company listed on the TSX Venture Exchange. The Company...

Continue reading

Irving Resources Reports 2021 Grant of Stock Options

Irving Resources Reports 2021 Grant of Stock Options

VANCOUVER, British Columbia, Dec. 21, 2021 (GLOBE NEWSWIRE) — Irving Resources Inc. (CSE:IRV; OTCQX: IRVRF) (“Irving” or the “Company”) announces that pursuant to the Company’s stock option plan, it has granted incentive stock options to its directors, officers, employees and consultants to purchase an aggregate of 1,745,000 common shares at an exercise price of $1.09 per share.  The stock options have a term of three (3) years, subject to one-third of the grant vesting every six (6) months from grant day with full vesting in the first 18 months of the term. About Irving Resources Inc.: Irving is a junior exploration company with a focus on gold in Japan. Irving also holds, through a subsidiary, a Joint Exploration Agreement with Japan Oil, Gas and Metals National Corporation (JOGMEC). JOGMEC is a government organization established...

Continue reading

MUZHU MINING CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT

MUZHU MINING CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT

Vancouver, BC, Dec. 21, 2021 (GLOBE NEWSWIRE) — Muzhu Mining Ltd. (CSE: MUZU) (“Muzhu” or the “Company”) is pleased to announce that due to increased interest in the Private Placement (News Release dated December 01, 2021) that the Company has oversubscribed its non-brokered private placement by 10 percent from 2,365,000 to 2,601,500 common shares designated as “flow-through” shares at a price of $0.17 per share for $442,255. The Issuer may pay finder’s fees, which may be paid to eligible finders in accordance with the CSE policies. All securities issued pursuant to the offering will be subject to a hold period of four months and one day from the date of closing. The offering and payment of finders’ fees are both subject to approval by the CSE. Muzhu owns 100% of the Sleeping Giant South Project (15,000...

Continue reading

Park National Corporation welcomes D. Byrd Miller III to Board of Directors

Park National Corporation welcomes D. Byrd Miller III to Board of Directors

D. Byrd Miller III D. Byrd Miller III Joins Park National Corporation Board of Directors NEWARK, Ohio, Dec. 21, 2021 (GLOBE NEWSWIRE) — Park National Corporation (NYSE American: PRK) (Park) announced today its Board of Directors elected D. Byrd Miller III to serve as a director, effective January 1, 2022. Miller will also join the Board of Directors of Park National Bank, Park’s banking subsidiary, effective on the same date. “Byrd has been connected to our organization as an advisory board member for our Carolina Division. He is a valued member of our leadership in the Carolinas and we look forward to having his voice at the board table,” Park Chairman and Chief Executive Officer David Trautman said. “He knows what we do, how we do it and why we exist — to help everyone with whom we come in contact flourish.” Miller...

Continue reading

Premier Health Reports Revenues of $66.6M for FY2021

Premier Health Reports Revenues of $66.6M for FY2021

MONTREAL, Dec. 21, 2021 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Audited Consolidated Financial Statements and MD&A for its fiscal year ended September 30, 2021. Summary The Corporation had revenues of $17.6M for the fourth quarter period ($66.6M for the 12-month period compared to $20.7M for the same period in 2020, a material increase attributable to the consolidation of the Code Bleu and Solution Nursing acquisitions as well as organic growth) The gross margin for the quarter was 25.1% (24.4% average for the 12-month period), in line with our long-term target of 25%. EBITDA(1) for the quarter was $1.7M ($5.9M for the 12-month period compared to $2.1M for the same period in 2020). Net income was $0.6M ($1.5M for the...

Continue reading

Consolidated Uranium Closes Acquisition of the Laguna Salada Uranium and Vanadium Project in Argentina

Consolidated Uranium Closes Acquisition of the Laguna Salada Uranium and Vanadium Project in Argentina

TORONTO, Dec. 21, 2021 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (“CUR” or the “Company”) (TSXV: CUR) (OTCQB: CURUF) is pleased to announce that it has closed the previously announced acquisition (the “Acquisition”) of a 100% undivided interest in the Laguna Salada uranium and vanadium project (“Laguna Salada” or the “Property”) located in Chubut Province, Argentina, pursuant to the option agreement (the “Option Agreement”) dated December 14, 2020 between Company and U308 Corp. (“U308”). CUR completed the Acquisition for consideration of $1,500,000 that was satisfied by the issuance of 675,675 common shares of the Company (“Common Shares”), at a deemed price of $2.22 per share based on the five-day volume weighted average price of the Common Shares up to June 9, 2021, being the second business day prior to the option being exercised....

Continue reading

AAR Reports Second Quarter Fiscal Year 2022 Results

AAR Reports Second Quarter Fiscal Year 2022 Results

Second quarter sales of $437 million, up 8% over the prior year Second quarter GAAP diluted earnings per share from continuing operations of $0.58 compared to $0.41 in Q2 FY2021 Adjusted diluted earnings per share from continuing operations of $0.53, up 71% from $0.31 in Q2 FY2021 Second quarter cash flow from operating activities from continuing operations of $16 million Announced $150 million share repurchase program WOOD DALE, Ill., Dec. 21, 2021 (GLOBE NEWSWIRE) — AAR CORP. (NYSE: AIR) today reported second quarter Fiscal Year 2022 consolidated sales of $436.6 million and income from continuing operations of $20.8 million, or $0.58 per diluted share. For the second quarter of the prior year, the Company reported sales of $403.6 million and income from continuing operations of $14.4 million, or $0.41 per diluted share. Our...

Continue reading

BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease

BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease

MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced it has entered into a Master Service Agreement with PRC Clinical, a contract research organization (CRO) specializing in clinical trial management to conduct BioRestorative’s Phase 2 clinical trial. PRC Clinical is an all-inclusive CRO and has specialized expertise across regenerative medicine, CNS, ophthalmology, pulmonary and COVID-19, rare and orphan disease and more complex indications. Their innovative approach to executing studies for biotech and pharmaceutical companies combines high-touch human elements and cutting-edge technology with extensive experience and deep therapeutic knowledge. Pursuant to the...

Continue reading

Astra Reminds Investors of the Redemption of Warrants

Astra Reminds Investors of the Redemption of Warrants

ALAMEDA, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Astra Space, Inc. (“Astra” or the “Company”) (Nasdaq: ASTR), announced that as of December 20, 2021, approximately 4.0 million public and private warrants (the “Redeemable Warrants”) have been exercised. As previously announced on November 26, 2021, the Company provided notice to the holders of the Redeemable Warrants that their warrants will be redeemed in accordance with the terms of the Redeemable Warrants if they are not exercised before 5:00 p.m. New York City time on December 27, 2021 (the “Redemption Date”). As a courtesy, the Company would like to remind any remaining holders of Redeemable Warrants that if the remaining approximately 11.3 million Redeemable Warrants are not exercised prior to the Redemption Date, they will be redeemed at the redemption price of $0.10 per...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.